EDGAR Filing Documents for 0000897069-03-000598

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0000897069-03-000598

Filing Date

2003-05-20

Accepted

2003-05-20 12:43:13

Documents

Period of Report

2003-05-16

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	irm345.txt	6-K	31035
	Complete submission text file	0000897069-03-000598.txt		32561

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 03711788
SIC: 2835 In Vitro & In Vivo Diagnostic Substances